Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 7746-29-4 | MDL No. : | MFCD07780793 |
Formula : | C9H10N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VDRWFBGSDLRPLK-UHFFFAOYSA-N |
M.W : | 162.19 | Pubchem ID : | 22290992 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 47.55 |
TPSA : | 37.91 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.93 cm/s |
Log Po/w (iLOGP) : | 1.59 |
Log Po/w (XLOGP3) : | 1.92 |
Log Po/w (WLOGP) : | 1.88 |
Log Po/w (MLOGP) : | 1.16 |
Log Po/w (SILICOS-IT) : | 2.45 |
Consensus Log Po/w : | 1.8 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.54 |
Solubility : | 0.463 mg/ml ; 0.00286 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.34 |
Solubility : | 0.742 mg/ml ; 0.00457 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.42 |
Solubility : | 0.0624 mg/ml ; 0.000385 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.44 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | Stage #1: With boron tribromide In dichloromethane at 20℃; Cooling with ice Stage #2: With water; sodium hydrogencarbonate In dichloromethaneCooling with ice |
To an ice cold solution of 6-methoxy-3-methyl-1 H-indazole (620 mg, 3.82 mmol) in CH2CI2 (25 mL) was added a solution of BBr3 in CH2CI2 (1 M, 17 ml_). The ice bath was removed and the reaction was allowed to warm to room temperature and stirred overnight. The solution was carefully quenched by slowly pouring into iced saturated aqueous NaHCO3. The phases were separated and the aqueous phase was extracted with EtOAc (3x). The combined organic extracts were concentrated and the crude material was purified Biotage (4OS column, 45-60percent acetone/heptane) to provide 3-methyl-1 H-indazol-6-ol (458 mg, 81 percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | Stage #1: With hydrazine hydrate In ethanol for 6 h; Reflux Stage #2: at 150℃; for 96 h; |
To a solution of l-(2-fluoro-4-methoxyphenyl)ethanone (4.85 g, 28.8 mmol) in ethanol (50 mL) was added hydrazine hydrate (5.61 mL, 115 mmoi) and the mixture was heated at reflux temperature for 6 h.This mixture was evaporated to dryness. Then, ethylene glycol (24. 12 rnL, 433 mmol) was added and the mixture was heated at 150°C for 96 h. After cooling to room temperature, the mixture was diluted with water (75 mL). A solid was formed and the suspension was stirred for 30 minutes. After filtration, indazole INT-1A (4.20 g, 26 rnmol, 90percent) was isolated as an off white solid. LCMS: calculated for [M+[-I1: 163, found: 163. |
78% | With hydrazine hydrate In 1-methyl-pyrrolidin-2-one at 120℃; for 24 h; Inert atmosphere | 1-(2-fluoro-4-methoxyphenyl)ethan-1-one (2 g, 11.9 mmol) was dissolved in 5 mL of a mixture of hydrazine hydrate (85percent) and NMP (15 mL). The mixture was stirred at 120 °C for 24 hours and purified by column chromatography to obtain 6-methoxy-3-methyl-1H-indazole (1.5 g, 78percent). |
59% | With hydrazine hydrate In ethanol; ethylene glycol | Step A: 6-Methoxy-3-methyl-1H-indazole To a solution of 2-fluoro-4-methoxyacetophenone (1.90 g, 11.3 mmol) in ethanol (20 ml) was added hydrazine hydrate (1.4 ml, 45.0 mmol) and heated at reflux temperature for 6 h. This mixture was evaporated to a residue and ethylene glycol (10 ml) was added. The mixture was heated at 150° C. for 18 h, cooled to room temperature, diluted with water (50 ml), and extracted with dichloromethane (3*60 ml). The combined extracts were washed with brine (10 ml), dried (MgSO4) and evaporated to a residue, which was crystallized from ethyl acetate to give a solid (1.1 g, 59percent): MS(ES) m/z 163 (M+). |
51% | With hydrazine hydrate In ethylene glycol | 6-Methoxy-3-methyl-1H-indazole To a stirred solution of 2'-fluoro-4'-methoxyacetophenone (0.5 g, 3.0 mmol) in ethylene glycol (10 mL) was added dropwise hydrazine hydrate (0.1 g, 3.1 mmol). The mixture was stirred for 24 h and partitioned between dichloromethane (20 mL) and water (3*20 mL). The organic layer was dried (magnesium sulfate), concentrated in vacuo and purified by column chromatography [SiO2; ethyl acetate-heptane (1:1)] to give an orange oil. The oil was dissolved in ethylene glycol (10 mL) and heated at 165° C. for 24 h. The solution was cooled to room temperature and partitioned between dichloromethane (20 mL) and water (3*20 mL). The organic extract was dried (magnesium sulfate), concentrated in vacuo and purified by column chromatography [SiO2; ethyl acetate-heptane (1:5)] to give the product (0.25 g, 51percent) as a colourless solid: IR νmax (Nujol/cm-1) 1624, 1519, 1458, 1295, 1208, 1170, 1024 and 821; NMR δH (400 MHz, CDCl3) 2.54 (3H, s), 3.86 (3H, s), 6.78-6.81 (2H, m) and 7.52 (1H, d, J 9 Hz). |
32% | for 48 h; Reflux | Acid Preparation 14; 3-Methyl-1 H-indazole-5-carboxvlic acid; A solution of 2-fluoro-4-methoxyactophenone (2.0 g, 12 mmol) in hydrazine hydrate (30 mL) was heated at reflux for two days. The mixture was cooled to room temperature, poured into water and extracted with EtOAc (3x). The organic extracts were concentrated, dissolved in a minimal amount of CH2CI2 and filtered to afford 6-methoxy-3-methyl-1 H- <n="51"/>indazole (370 mg, 19percent). The filtrate was refiltered to provide additional product (250 mg, 13percent). |
32% | for 48 h; Heating / reflux | A solution of 2-fluoro-4-methoxyacetophenone (2.0 g, 12 mmol) in hydrazine (30 mL) was heated at reflux for 2 days. The mixture was cooled to room temperature, poured into water and extracted with EtOAc (3x). The combined organic extracts were concentrated, dissolved in a minimum amount of CH2CI2, filtered to provide 6-methoxy-3-methyl-1 H-indazole as a yellow solid (620 mg, 32percent).To a solution of 6-methoxy-3-methyl-1 H-indazole (620 mg, 3.82 mol) in CH2CI2 (25 mL) at 0 0C was added a dichloromethane solution of boron tribromide (17 mL of 1 M solution). The mixture was stirred at room temperature overnight. The solution was carefully quenched by pouring slowly into iced saturated aqueous NaHCO3. The phases were separated and the aqueous phase was extracted with EtOAc (3x). The combined organic extracts were concentrated and the crude material was purified by Biotage chromatography (4OS column, acetone/heptane 45percent 500 mL and 60percent 150 mL) to provide 3-methyl-1H- . indazoJr6-ol as an orange, solid (458 mg, 81percent).A solution of 3-methyl-1 H-indazol-6:l (458 mg73.1 "mmol) in THF (30 mL) was treated with sodium hydride (0.50 g of 60percent oil dispersion). After the initial effervescence had subsided, the solution was heated to 50 0C for 1 hour before cooling to room temperature and adding N-phenyltrifluoromethane- sulphonimide (2.50 g, 7.0 mmol). The mixture was stirred at room temperature for 2 hours before pouring " into water.TheraqueTjus phase was extracted with EtOAc (3x). The combined organic extracts were concentrated and the crude material was purified by Biotage chromatography (4OM column, 12percent acetone/heptane). To provide 3-methyl-1-(trifluoromethylsulfonyi)-1H-indazol-6-yl trifluoromethanesulfonate (1.13 g, 89percent).A solution of 3-methyl-1-(trifluoromethylsulfonyl)-1 H-indazol-6-yl trifluoromethanesulfonate (0.61 g, 1.5 mmol) in DMF (6 mL) was flushed with carbon dioxide for 5 minutes. To this was added palladium acetate (68 mg, 0.30 mmol), 1,1 -bis(diphenylphosino)ferrocene (167 mg, 0.30 mmol), triethylamine (0.33 g, 0.45 mL, 3.2 mmol), and methanol (4 mL). The solution was stirred at room temperature overnight under one atmosphere of CO. The solution was poured into water and extracted with EtOAc (3x). The combined organic extracts were concentrated and purified by Biotage chromatography (4OS column, 8percent EtOAc/heptanes) to provide methyl 3-methyl-1-(trifluoromethylsulfonyl)-1 H-indazole-6-carboxylate (330 mg, 69percent). <n="32"/>To a solution of 3-methyl-1-(trifluoromethylsulfonyl)-1 H-indazole-6-carboxylate (590 mg, 1.83 mmol) in MeOH/water (3:1 , 72 mL) was added potassium carbonate (1.01 g, 7.31 mmol) and the mixture was heated at reflux for 2 hours. The mixture was cooled to room temperature and methanol was removed under reduced pressure. The aqueous solution was acidified with KHSO4 to pH 3 - 3.5. The white precipitate that formed was isolated by vacuum filtration, dissolved in EtOAc and washed with water. The organic extract was dried over MgSO4, filtered, concentrated and dried to yield the title compound as a white solid (259 mg, 80percent). |
4.2 g | at 140℃; for 20 h; | To 2'-fluoro-4'-methoxyacetophenone (5.24 g) was added hydrazine monohydrate (20 mL) at room temperature, and then the reaction mixture was stirred at 140°C for 20 hours. The precipitated solid was filtered to give the titled compound (4.20 g) as a red solid. 1H-NMR (400 MHz, CDCl3) δ:7.52 (1H, d, J=9.3 Hz), 6.80-6.78 (2H, m), 3.86 (3H, s), 2.54 (3H, s). |